Brown Capital Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-1,484
| Closed | -$223K | – | 88 |
|
2025
Q1 | $223K | Sell |
1,484
-675
| -31% | -$102K | 0.01% | 102 |
|
2024
Q4 | $399K | Sell |
2,159
-4,387
| -67% | -$810K | 0.01% | 96 |
|
2024
Q3 | $1.29M | Sell |
6,546
-13,542
| -67% | -$2.67M | 0.03% | 70 |
|
2024
Q2 | $4.15M | Sell |
20,088
-2,876
| -13% | -$594K | 0.08% | 60 |
|
2024
Q1 | $6.22M | Sell |
22,964
-185
| -0.8% | -$50.1K | 0.11% | 54 |
|
2023
Q4 | $5.47M | Sell |
23,149
-766
| -3% | -$181K | 0.08% | 52 |
|
2023
Q3 | $4.69M | Buy |
23,915
+1,725
| +8% | +$338K | 0.07% | 52 |
|
2023
Q2 | $4.67M | Buy |
22,190
+7,727
| +53% | +$1.62M | 0.07% | 55 |
|
2023
Q1 | $2.92M | Buy |
14,463
+1,699
| +13% | +$343K | 0.04% | 63 |
|
2022
Q4 | $2.78M | Sell |
12,764
-2,427
| -16% | -$529K | 0.05% | 62 |
|
2022
Q3 | $2.99M | Sell |
15,191
-13
| -0.1% | -$2.56K | 0.04% | 59 |
|
2022
Q2 | $3.25M | Buy |
15,204
+1,195
| +9% | +$256K | 0.04% | 54 |
|
2022
Q1 | $3.98M | Buy |
14,009
+399
| +3% | +$113K | 0.04% | 55 |
|
2021
Q4 | $5.13M | Buy |
13,610
+354
| +3% | +$133K | 0.04% | 55 |
|
2021
Q3 | $5.47M | Buy |
13,256
+2,021
| +18% | +$834K | 0.04% | 52 |
|
2021
Q2 | $4.16M | Buy |
11,235
+570
| +5% | +$211K | 0.03% | 54 |
|
2021
Q1 | $3.09M | Hold |
10,665
| – | – | 0.02% | 65 |
|
2020
Q4 | $2.67M | Buy |
10,665
+330
| +3% | +$82.5K | 0.02% | 67 |
|
2020
Q3 | $2.34M | Buy |
10,335
+243
| +2% | +$55K | 0.02% | 63 |
|
2020
Q2 | $1.76M | Buy |
10,092
+3,649
| +57% | +$636K | 0.02% | 72 |
|
2020
Q1 | $813K | Buy |
6,443
+381
| +6% | +$48.1K | 0.01% | 83 |
|
2019
Q4 | $686K | Hold |
6,062
| – | – | 0.01% | 96 |
|
2019
Q3 | $802K | Buy |
+6,062
| New | +$802K | 0.01% | 93 |
|